Pricing Log in Create free account

GENPREX (GNPX) vs Oragenics, Inc. (OGEN)

GENPREX and Oragenics, Inc. are both Biotechnology companies. GENPREX and Oragenics, Inc. are of similar size ($2.0M and $1.9M). GENPREX trades at the lower P/E: 0.0× against 0.4×. Across the 10 metrics below, GENPREX leads on 8 and Oragenics, Inc. on 2.

Valuation

Metric GNPX OGEN Biotechnology median
P/E 0.03 0.38 8.50
P/S n/m 15.40 9.71
P/B 0.07 0.52 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.89 n/m 0.64
EV/Sales n/m 3.56 9.21
Earnings yield 3,170.61% 259.93% (33.15%)
Free cash flow yield (1,481.72%) (534.75%) (25.50%)

Profitability

Metric GNPX OGEN Biotechnology median
Gross margin 0.00% 19.89% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (203.86%) (1,307.07%) (56.36%)
Return on assets (157.40%) (264.23%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GNPX OGEN Biotechnology median
Revenue growth (TTM) — (75.08%) 6.02%
EPS growth (last fiscal year) 93.48% 90.51% 30.26%
Revenue growth, 5-year CAGR — (50.98%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GNPX OGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.76 3.01 4.72
Net debt to EBITDA 0.50 0.98 0.96

Dividend

Metric GNPX OGEN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GNPX OGEN Biotechnology median
Market cap 1.88m 1.97m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack